Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Entamoeba histolytica | protein kinase, putative | 0.0088 | 0.0222 | 0.1422 |
Schistosoma mansoni | serine/threonine-protein kinase | 0.0171 | 0.0666 | 1 |
Schistosoma mansoni | serine/threonine kinase | 0.0088 | 0.0222 | 0.2528 |
Loa Loa (eye worm) | AGC/DMPK/GEK protein kinase | 0.0088 | 0.0222 | 0.0222 |
Giardia lamblia | Multidrug resistance-associated protein 1 | 0.006 | 0.0072 | 0.0044 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0088 | 0.0222 | 0.2528 |
Echinococcus multilocularis | Glutaredoxin protein 5 | 0.0169 | 0.0656 | 0.9828 |
Giardia lamblia | MRP-like ABC transporter | 0.006 | 0.0072 | 0.0044 |
Giardia lamblia | Kinase, AGC PKA | 0.0171 | 0.0666 | 1 |
Trypanosoma brucei | rac serine-threonine kinase, putative | 0.0257 | 0.1129 | 1 |
Giardia lamblia | Multidrug resistance-associated protein 1 | 0.006 | 0.0072 | 0.0044 |
Brugia malayi | protein kinase C II. | 0.0088 | 0.0222 | 0.1422 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0088 | 0.0222 | 0.2528 |
Echinococcus multilocularis | serine threonine protein kinase nrc serine threonine protein kinase gad | 0.0171 | 0.0666 | 1 |
Loa Loa (eye worm) | AGC/PKC/ETA protein kinase | 0.0088 | 0.0222 | 0.0222 |
Trypanosoma cruzi | Protein kinase B | 0.0171 | 0.0666 | 1 |
Leishmania major | p-glycoprotein e | 0.006 | 0.0072 | 0.5 |
Entamoeba histolytica | protein kinase, putative | 0.0257 | 0.1129 | 1 |
Echinococcus granulosus | Ribosomal protein S6 kinase beta 2 | 0.0088 | 0.0222 | 0.2528 |
Trichomonas vaginalis | AGC family protein kinase | 0.0088 | 0.0222 | 0.0111 |
Leishmania major | ATP-binding cassette protein subfamily C, member 1, putative | 0.006 | 0.0072 | 0.5 |
Echinococcus granulosus | NDR protein kinase | 0.0088 | 0.0222 | 0.2528 |
Trichomonas vaginalis | AGC family protein kinase | 0.0257 | 0.1129 | 1 |
Loa Loa (eye worm) | ABC transporter transmembrane region family protein | 0.006 | 0.0072 | 0.0072 |
Echinococcus multilocularis | sodium:potassium dependent atpase beta subunit | 0.0169 | 0.0656 | 0.9828 |
Echinococcus multilocularis | Protein kinase C, brain isozyme | 0.0088 | 0.0222 | 0.2528 |
Echinococcus multilocularis | serine:threonine protein kinase 38 | 0.0088 | 0.0222 | 0.2528 |
Trichomonas vaginalis | AGC family protein kinase | 0.0088 | 0.0222 | 0.0111 |
Echinococcus granulosus | Protein kinase C brain isozyme | 0.0088 | 0.0222 | 0.2528 |
Trichomonas vaginalis | AGC family protein kinase | 0.0257 | 0.1129 | 1 |
Trichomonas vaginalis | AGC family protein kinase | 0.0257 | 0.1129 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0088 | 0.0222 | 0.0222 |
Echinococcus granulosus | calcium:calmodulin dependent protein kinase | 0.0171 | 0.0666 | 1 |
Loa Loa (eye worm) | AGC/RSK/P70 protein kinase | 0.0257 | 0.1129 | 0.1129 |
Trichomonas vaginalis | AGC family protein kinase | 0.0088 | 0.0222 | 0.0111 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0088 | 0.0222 | 0.2528 |
Echinococcus granulosus | serine:threonine protein kinase N2 | 0.0088 | 0.0222 | 0.2528 |
Echinococcus granulosus | serine threonine protein kinase nrc | 0.0171 | 0.0666 | 1 |
Echinococcus granulosus | serine/threonine protein kinase | 0.0171 | 0.0666 | 1 |
Brugia malayi | Hr1 repeat family protein | 0.0088 | 0.0222 | 0.1422 |
Schistosoma mansoni | serine/threonine-protein kinase | 0.0171 | 0.0666 | 1 |
Echinococcus granulosus | Glutaredoxin protein 5 | 0.0169 | 0.0656 | 0.9828 |
Echinococcus multilocularis | Ribosomal protein S6 kinase beta 2 | 0.0088 | 0.0222 | 0.2528 |
Echinococcus granulosus | ribosomal protein s6 kinase beta 1 | 0.0088 | 0.0222 | 0.2528 |
Echinococcus granulosus | protein kinase c epsilon type | 0.0088 | 0.0222 | 0.2528 |
Echinococcus granulosus | sodium:potassium dependent atpase beta subunit | 0.0169 | 0.0656 | 0.9828 |
Toxoplasma gondii | hypothetical protein | 0.1912 | 1 | 1 |
Echinococcus granulosus | nervana 2 | 0.0169 | 0.0656 | 0.9828 |
Echinococcus multilocularis | serine:threonine protein kinase N2 | 0.0088 | 0.0222 | 0.2528 |
Echinococcus multilocularis | serine:threonine protein kinase N2 | 0.0088 | 0.0222 | 0.2528 |
Brugia malayi | Protein kinase domain containing protein | 0.0088 | 0.0222 | 0.1422 |
Echinococcus multilocularis | nervana 2 | 0.0169 | 0.0656 | 0.9828 |
Trichomonas vaginalis | AGC family protein kinase | 0.0257 | 0.1129 | 1 |
Leishmania major | ATP-binding cassette protein subfamily C, member 6, putative | 0.006 | 0.0072 | 0.5 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0088 | 0.0222 | 0.2528 |
Leishmania major | ATP-binding cassette protein subfamily C, member 5, putative | 0.006 | 0.0072 | 0.5 |
Trichomonas vaginalis | AGC family protein kinase | 0.0257 | 0.1129 | 1 |
Echinococcus granulosus | protein kinase C gamma type | 0.0088 | 0.0222 | 0.2528 |
Trichomonas vaginalis | AGC family protein kinase | 0.0257 | 0.1129 | 1 |
Entamoeba histolytica | PH domain containing protein kinase, putative | 0.0171 | 0.0666 | 0.5624 |
Echinococcus multilocularis | ribosomal protein S6 kinase alpha 3 | 0.0088 | 0.0222 | 0.2528 |
Leishmania major | pentamidine resistance protein 1 | 0.006 | 0.0072 | 0.5 |
Loa Loa (eye worm) | AGC/AKT protein kinase | 0.0257 | 0.1129 | 0.1129 |
Loa Loa (eye worm) | hypothetical protein | 0.006 | 0.0072 | 0.0072 |
Entamoeba histolytica | protein kinase 2, putative | 0.0171 | 0.0666 | 0.5624 |
Giardia lamblia | ABC transporter, putative | 0.006 | 0.0072 | 0.0044 |
Entamoeba histolytica | protein kinase, putative | 0.0257 | 0.1129 | 1 |
Trichomonas vaginalis | AGC family protein kinase | 0.0088 | 0.0222 | 0.0111 |
Echinococcus multilocularis | protein kinase c iota type | 0.0088 | 0.0222 | 0.2528 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0088 | 0.0222 | 0.2528 |
Echinococcus multilocularis | protein kinase c epsilon type | 0.0088 | 0.0222 | 0.2528 |
Brugia malayi | Protein kinase domain containing protein | 0.0088 | 0.0222 | 0.1422 |
Trypanosoma cruzi | rac serine-threonine kinase, putative | 0.0171 | 0.0666 | 1 |
Schistosoma mansoni | atypical protein kinase C | 0.0088 | 0.0222 | 0.2528 |
Loa Loa (eye worm) | AGC/RSK/MSK protein kinase | 0.0088 | 0.0222 | 0.0222 |
Loa Loa (eye worm) | inward rectifying k channel family protein 1 | 0.1912 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.1912 | 1 | 1 |
Loa Loa (eye worm) | AGC/RSK/RSK protein kinase | 0.0088 | 0.0222 | 0.0222 |
Toxoplasma gondii | AGC kinase | 0.0257 | 0.1129 | 0.1064 |
Entamoeba histolytica | PH domain containing protein kinase, putative | 0.0171 | 0.0666 | 0.5624 |
Entamoeba histolytica | protein kinase, putative | 0.0257 | 0.1129 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.006 | 0.0072 | 0.0072 |
Trichomonas vaginalis | AGC family protein kinase | 0.0257 | 0.1129 | 1 |
Brugia malayi | Protein kinase domain containing protein | 0.0257 | 0.1129 | 1 |
Loa Loa (eye worm) | AGC/PKN protein kinase | 0.0088 | 0.0222 | 0.0222 |
Echinococcus multilocularis | serine threonine protein kinase | 0.0088 | 0.0222 | 0.2528 |
Echinococcus multilocularis | nervana 2 | 0.0169 | 0.0656 | 0.9828 |
Loa Loa (eye worm) | hypothetical protein | 0.006 | 0.007 | 0.007 |
Echinococcus granulosus | ribosomal protein S6 kinase alpha 3 | 0.0088 | 0.0222 | 0.2528 |
Plasmodium vivax | rac-beta serine/threonine protein kinase, putative | 0.0171 | 0.0666 | 0.5 |
Leishmania major | ABC-thiol transporter | 0.006 | 0.0072 | 0.5 |
Brugia malayi | p70 ribosomal S6 kinase beta | 0.0257 | 0.1129 | 1 |
Echinococcus multilocularis | ribosomal protein s6 kinase beta 1 | 0.0088 | 0.0222 | 0.2528 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0088 | 0.0222 | 0.2528 |
Echinococcus granulosus | nervana 2 | 0.0169 | 0.0656 | 0.9828 |
Echinococcus multilocularis | rac serine:threonine kinase | 0.0171 | 0.0666 | 1 |
Leishmania major | ATP-binding cassette protein subfamily C, member 2, putative | 0.006 | 0.0072 | 0.5 |
Plasmodium falciparum | RAC-beta serine/threonine protein kinase | 0.0171 | 0.0666 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.1912 | 1 | 1 |
Echinococcus granulosus | protein kinase c iota type | 0.0088 | 0.0222 | 0.2528 |
Trypanosoma cruzi | rac serine-threonine kinase, putative | 0.0171 | 0.0666 | 1 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0088 | 0.0222 | 0.2528 |
Loa Loa (eye worm) | AGC/NDR protein kinase | 0.0088 | 0.0222 | 0.0222 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Cell no./dish x10E3 (functional) | = 2.2 | Inhibition of [3H]-thymidine incorporation into hormone independent MDA-MB 231 human breast cancer cells at 1x10E-5 M | ChEMBL. | 6402593 |
Cell no./dish x10E3 (functional) | = 36.4 | Inhibition of [3H]-thymidine incorporation into hormone independent MDA-MB 231 human breast cancer cells at 1x10E-6M | ChEMBL. | 6402593 |
Cell no./dish x10E5 (functional) | = 4.12 | Inhibition of [3H]-thymidine incorporation into hormone independent MDA-MB 231 human breast cancer cells at 1x10E-5 M | ChEMBL. | 6402593 |
Cell no./dish x10E5 (functional) | = 10.12 | Inhibition of [3H]-thymidine incorporation into hormone independent MDA-MB 231 human breast cancer cells at 1x10E-6M | ChEMBL. | 6402593 |
Change (functional) | = -2 % | Change in body weight of DMBA-induced hormone dependent mammary carcinoma tumour bearing rats at 2 mg/kg after 7 day therapy in 9 animals | ChEMBL. | 6402593 |
Change (functional) | = 24 % | Change in tumor area DMBA-induced hormone dependent mammary carcinoma tumour bearing rats at 2 mg/kg after 7 day therapy in 9 animals | ChEMBL. | 6402593 |
Complete remission (functional) | = 19 % | Percent complete remission of DMBA-induced hormone dependent mammary carcinoma in rats at 2 mg/kg in 9 animals | ChEMBL. | 6402593 |
Effect (functional) | = 16 | Estrogenic activity in mouse uterotrophic assay at 1 ug as uterus dry weight(mg)/body weight (g) *100 | ChEMBL. | 6402593 |
Effect (functional) | = 18.2 | Estrogenic activity in mouse uterotrophic assay at 5 ug as uterus dry weight(mg)/body weight (g) *100 | ChEMBL. | 6402593 |
Effect (functional) | = 26 | Estrogenic activity in mouse uterotrophic assay at 25 ug as uterus dry weight(mg)/body weight (g) *100 | ChEMBL. | 6402593 |
Effect (functional) | = 34.4 | Estrogenic activity in mouse uterotrophic assay at 125 ug as uterus dry weight(mg)/body weight (g) *100 | ChEMBL. | 6402593 |
Effect (functional) | = 37.7 | Anti-estrogenic activity in mouse uterotrophic assay at 125 ug as uterus dry weight(mg)/body weight (g) *100 | ChEMBL. | 6402593 |
Effect (functional) | = 39.6 | Anti-estrogenic activity in mouse uterotrophic assay at 625 ug as uterus dry weight(mg)/body weight (g) *100 | ChEMBL. | 6402593 |
Effect (functional) | = 40.1 | Estrogenic activity in mouse uterotrophic assay at 625 ug as uterus dry weight(mg)/body weight (g) *100 | ChEMBL. | 6402593 |
Effect (functional) | = 42.7 | Anti-estrogenic activity in mouse uterotrophic assay at 25 ug as uterus dry weight(mg)/body weight (g) *100 | ChEMBL. | 6402593 |
Effect (functional) | = 45.4 | Anti-estrogenic activity in mouse uterotrophic assay at 5 ug as uterus dry weight(mg)/body weight (g) *100 | ChEMBL. | 6402593 |
Effect (functional) | = 48.5 | Anti-estrogenic activity in mouse uterotrophic assay at 1 ug as uterus dry weight(mg)/body weight (g) *100 | ChEMBL. | 6402593 |
Effect (functional) | = 16 | Estrogenic activity in mouse uterotrophic assay at 1 ug as uterus dry weight(mg)/body weight (g) *100 | ChEMBL. | 6402593 |
Effect (functional) | = 18.2 | Estrogenic activity in mouse uterotrophic assay at 5 ug as uterus dry weight(mg)/body weight (g) *100 | ChEMBL. | 6402593 |
Effect (functional) | = 26 | Estrogenic activity in mouse uterotrophic assay at 25 ug as uterus dry weight(mg)/body weight (g) *100 | ChEMBL. | 6402593 |
Effect (functional) | = 34.4 | Estrogenic activity in mouse uterotrophic assay at 125 ug as uterus dry weight(mg)/body weight (g) *100 | ChEMBL. | 6402593 |
Effect (functional) | = 37.7 | Anti-estrogenic activity in mouse uterotrophic assay at 125 ug as uterus dry weight(mg)/body weight (g) *100 | ChEMBL. | 6402593 |
Effect (functional) | = 39.6 | Anti-estrogenic activity in mouse uterotrophic assay at 625 ug as uterus dry weight(mg)/body weight (g) *100 | ChEMBL. | 6402593 |
Effect (functional) | = 40.1 | Estrogenic activity in mouse uterotrophic assay at 625 ug as uterus dry weight(mg)/body weight (g) *100 | ChEMBL. | 6402593 |
Effect (functional) | = 42.7 | Anti-estrogenic activity in mouse uterotrophic assay at 25 ug as uterus dry weight(mg)/body weight (g) *100 | ChEMBL. | 6402593 |
Effect (functional) | = 45.4 | Anti-estrogenic activity in mouse uterotrophic assay at 5 ug as uterus dry weight(mg)/body weight (g) *100 | ChEMBL. | 6402593 |
Effect (functional) | = 48.5 | Anti-estrogenic activity in mouse uterotrophic assay at 1 ug as uterus dry weight(mg)/body weight (g) *100 | ChEMBL. | 6402593 |
Inhibition (functional) | = -6 % | Percent inhibition in anti-uterotrophic assay in mice at 1 ug | ChEMBL. | 6402593 |
Inhibition (functional) | = -6 % | Percent inhibition in anti-uterotrophic assay in mice at 1 ug | ChEMBL. | 6402593 |
Inhibition (functional) | = 5 % | Percent inhibition in anti-uterotrophic assay in mice at 5 ug | ChEMBL. | 6402593 |
Inhibition (functional) | = 5 % | Percent inhibition in anti-uterotrophic assay in mice at 5 ug | ChEMBL. | 6402593 |
Inhibition (functional) | = 14 % | Percent inhibition in anti-uterotrophic assay in mice at 25 ug | ChEMBL. | 6402593 |
Inhibition (functional) | = 14 % | Percent inhibition in anti-uterotrophic assay in mice at 25 ug | ChEMBL. | 6402593 |
Inhibition (functional) | = 24 % | Percent inhibition in anti-uterotrophic assay in mice at 625 ug | ChEMBL. | 6402593 |
Inhibition (functional) | = 24 % | Percent inhibition in anti-uterotrophic assay in mice at 625 ug | ChEMBL. | 6402593 |
Inhibition (functional) | = 30 % | Percent inhibition in anti-uterotrophic assay in mice at 125 ug | ChEMBL. | 6402593 |
Inhibition (functional) | = 30 % | Percent inhibition in anti-uterotrophic assay in mice at 125 ug | ChEMBL. | 6402593 |
New tumors (functional) | = 24 | New tumor development in DMBA-induced hormone dependent mammary carcinoma in rats at 6 mg/kg | ChEMBL. | 6402593 |
No. of tumors (functional) | = 19 | Initial DMBA-induced hormone dependent mammary carcinoma tumours in rats at 6 mg/kg | ChEMBL. | 6402593 |
Partial remission (functional) | = 28 % | Partial remission in DMBA-induced hormone dependent mammary carcinoma tumour bearing rats at 2 mg/kg in 9 animals | ChEMBL. | 6402593 |
Progressed remission (functional) | = 28 % | Progressive DMBA-induced hormone dependent mammary carcinoma tumours in rats at 2 mg/kg in 9 animals | ChEMBL. | 6402593 |
Static remission (functional) | = 25 % | Static unchanged DMBA-induced hormone dependent mammary carcinoma tumours in rats at 2 mg/kg in 9 animals | ChEMBL. | 6402593 |
T/C (functional) | = 5 % | Inhibition of [3H]-thymidine incorporation into hormone independent MDA-MB 231 human breast cancer cells at 1*10-5 M | ChEMBL. | 6402593 |
T/C (functional) | = 5 % | Inhibition of [3H]-thymidine incorporation into hormone independent MDA-MB 231 human breast cancer cells at 1*10-5 M | ChEMBL. | 6402593 |
T/C (functional) | = 38 % | Inhibition of [3H]-thymidine incorporation into hormone independent MDA-MB 231 human breast cancer cells at 1x10E-5 M | ChEMBL. | 6402593 |
T/C (functional) | = 38 % | Inhibition of [3H]-thymidine incorporation into hormone independent MDA-MB 231 human breast cancer cells at 1x10E-5 M | ChEMBL. | 6402593 |
T/C (functional) | = 88 % | Inhibition of [3H]-thymidine incorporation into hormone independent MDA-MB 231 human breast cancer cells at 1x10E-6M | ChEMBL. | 6402593 |
T/C (functional) | = 88 % | Inhibition of [3H]-thymidine incorporation into hormone independent MDA-MB 231 human breast cancer cells at 1x10E-6M | ChEMBL. | 6402593 |
T/C (functional) | = 95 % | Inhibition of [3H]-thymidine incorporation into hormone independent MDA-MB 231 human breast cancer cells at 1x10E-6M | ChEMBL. | 6402593 |
T/C (functional) | = 95 % | Inhibition of [3H]-thymidine incorporation into hormone independent MDA-MB 231 human breast cancer cells at 1x10E-6M | ChEMBL. | 6402593 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.